SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-222403
Filing Date
2022-08-16
Accepted
2022-08-16 17:03:53
Documents
15
Period of Report
2022-08-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d284938d8k.htm   iXBRL 8-K 29863
2 EX-99.1 d284938dex991.htm EX-99.1 9309
3 EX-99.2 d284938dex992.htm EX-99.2 6280
7 GRAPHIC g284938g0816093131971.jpg GRAPHIC 2713
  Complete submission text file 0001193125-22-222403.txt   181974

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA inab-20220811.xsd EX-101.SCH 2843
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE inab-20220811_lab.xml EX-101.LAB 18739
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inab-20220811_pre.xml EX-101.PRE 11699
9 EXTRACTED XBRL INSTANCE DOCUMENT d284938d8k_htm.xml XML 3453
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39692 | Film No.: 221170956
SIC: 2836 Biological Products, (No Diagnostic Substances)